ACR appropriateness criteria® hemoptysis

Area of Science:

• Pulmonology
• Radiology
• Interventional Radiology

Background:

• Hemoptysis, though often benign, can indicate severe underlying conditions such as bronchiectasis, infections, or lung cancer.
• Severity grading of hemoptysis is based on blood volume: minor (<30 mL), major (30-300 mL), and massive (>300-400 mL/24h).
• Chest radiography is a common initial evaluation tool for hemoptysis, with abnormalities guiding further assessment.

Purpose of the Study:

• To review the ACR Appropriateness Criteria for the evaluation and management of hemoptysis.
• To highlight diagnostic pathways and treatment options for various severities of hemoptysis.
• To emphasize the role of imaging and interventional procedures in diagnosing and treating hemoptysis.

Main Methods:

• Review of current medical literature from peer-reviewed journals.
• Application of a modified Delphi consensus methodology by a multidisciplinary expert panel.
• Evidence-based guideline development for imaging and treatment procedures.

Main Results:

• Malignancy risk in hemoptysis patients with normal radiographs is low, but increases with hemoptysis volume and in older, smoking patients.
• Negative computed tomography and bronchoscopy predict a low likelihood of lung malignancy over 2-3 years.
• Bronchial artery embolization is effective for acute control of major/massive hemoptysis, though recurrences are common.

Conclusions:

• Hemoptysis evaluation requires a systematic approach, considering patient factors and bleeding severity.
• Imaging modalities like CT and bronchoscopy play key roles in diagnosis, especially for suspected malignancy.
• Bronchial artery embolization is a primary treatment for severe hemoptysis, with potential need for repeat interventions.